Home
Therapeutic Areas
Science
Team
News
Select Page
ProThera Biologics and Takeda Enter Global Licensing Agreement to Develop Novel Plasma-Derived Therapy Based on Inter-alpha Inhibitor Proteins (IAIP)
Read the Full Announcement
×
